{
  "docId": "019de076-9b15-737c-b05c-8347f7a98ad7",
  "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 28,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide contrasts the traditional CRO outsourcing model with a direct management model to justify cost efficiency.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/26",
  "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7",
  "deckJsonHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7.json",
  "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Biotech companies often outsource the full study to a CRO\nThere are large costs associated with layers of project management in this model and risks to meeting regulatory requirements by ceding full control\nInitial estimates based upon prior experience with the full-service CRO model aggregated to approximately $20 Million for the Phase I/IIa study\nBy adopting a model where Renovaro assumes more of the project management and parses out responsibility to vendors, focusing on their strengths without their overhead costs...\nBudget reduced by an estimated 50% while maintaining full control and full-service",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6aec4ad-e143-4f63-914d-76c4a1ccc245",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "title",
      "text": "RENB-DC11-01 STUDY STRATEGY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98cde4d4-d8f3-4c72-a772-df3f3917a8a1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "2c1a0a57-3287-47f1-9ad0-647cf91c7425",
      "evidence": "list/bullet: Biotech companies often outsource the full study to a CRO",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 5,
      "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}